🏅 FDA Orphan Designation
EXSERVAN
riluzole oral film
Manufacturer: Aquestive Therapeutics
Indicated for:
FDA-Approved Indications (1)
Amyotrophic Lateral Sclerosis (ALS)Orphan Designation
EXSERVAN is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Indications & Usage
EXSERVAN is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
💙 Support Programs
View all →EXSERVAN
Aquestive Therapeutics
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.